drugset / Trial / NCT03371342
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the safety of MEDITOXIN in female subjects with idiopathic overactive bladder compared with BOTOX
Timeline
- Start
- 2017-12-13
- Primary completion
- 2018-05-31
- Completion
- 2018-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |